OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts
Diana L. Bernstein, John E. Le Lay, Elena G. Ruano, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 5, pp. 1998-2006
Open Access | Times Cited: 123

Showing 26-50 of 123 citing articles:

DNA methylation profiling in human lung tissue identifies genes associated with COPD
Jarrett D. Morrow, Michael H. Cho, Craig P. Hersh, et al.
Epigenetics (2016) Vol. 11, Iss. 10, pp. 730-739
Open Access | Times Cited: 86

Next stop for the CRISPR revolution: RNA‐guided epigenetic regulators
Suhani Vora, Marcelle Tuttle, Jenny Cheng, et al.
FEBS Journal (2016) Vol. 283, Iss. 17, pp. 3181-3193
Open Access | Times Cited: 75

Targeted demethylation at the CDKN1C/p57 locus induces human β cell replication
Kristy Ou, Ming Yu, Nicholas Moss, et al.
Journal of Clinical Investigation (2018) Vol. 129, Iss. 1, pp. 209-214
Open Access | Times Cited: 60

Epigenome engineering: new technologies for precision medicine
Agustin Sgro, Pilar Blancafort
Nucleic Acids Research (2020) Vol. 48, Iss. 22, pp. 12453-12482
Open Access | Times Cited: 54

Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis
Hadrien De Blander, Anne‐Pierre Morel, Aruni P. Senaratne, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4561-4561
Open Access | Times Cited: 49

Epigenomics and human adaptation to high altitude
Colleen G. Julian
Journal of Applied Physiology (2017) Vol. 123, Iss. 5, pp. 1362-1370
Open Access | Times Cited: 58

Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will
David Cano-Rodríguez, Marianne G. Rots
Current Genetic Medicine Reports (2016) Vol. 4, Iss. 4, pp. 170-179
Open Access | Times Cited: 57

Strategies for precision modulation of gene expression by epigenome editing: an overview
Benjamin I. Laufer, Shiva M. Singh
Epigenetics & Chromatin (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 56

The epigenome: the next substrate for engineering
Minhee Park, Albert J. Keung, Ahmad S. Khalil
Genome biology (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 55

The Dysregulation of the DLK1-MEG3 Locus in Islets From Patients With Type 2 Diabetes Is Mimicked by Targeted Epimutation of Its Promoter With TALE-DNMT Constructs
Vasumathi Kameswaran, Maria L. Golson, Mireia Ramos-Rodríguez, et al.
Diabetes (2018) Vol. 67, Iss. 9, pp. 1807-1815
Open Access | Times Cited: 54

DNA methylation and de-methylation using hybrid site-targeting proteins
Yong Lei, Yung‐Hsin Huang, Margaret A. Goodell
Genome biology (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 54

Frequent lack of repressive capacity of promoter DNA methylation identified through genome-wide epigenomic manipulation
Ethan Ford, Matthew Grimmer, Sabine Stolzenburg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2017)
Closed Access | Times Cited: 51

Editing the Epigenome to Tackle Brain Disorders
X. Shawn Liu, Rudolf Jaenisch
Trends in Neurosciences (2019) Vol. 42, Iss. 12, pp. 861-870
Closed Access | Times Cited: 51

Successful generation of epigenetic disease model mice by targeted demethylation of the epigenome
Takuro Horii, Sumiyo Morita, Shinjiro Hino, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 49

Engineering of Effector Domains for Targeted DNA Methylation with Reduced Off-Target Effects
Daniel Tobias Hofacker, Julian Broche, Laura Laistner, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 502-502
Open Access | Times Cited: 47

CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review
Linn Amanda Syding, Petr Nickl, Petr Kašpárek, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 993-993
Open Access | Times Cited: 42

Epigenetic editing: Dissecting chromatin function in context
Cristina Policarpi, Juliette Dabin, Jamie A. Hackett
BioEssays (2021) Vol. 43, Iss. 5
Closed Access | Times Cited: 39

Epigenetic Editing of Ascl1 Gene in Neural Stem Cells by Optogenetics
Chiao-Ling Lo, Samrat Roy Choudhury, Joseph Irudayaraj, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 48

CRISPR-Mediated Epigenome Editing.
Paul Enríquez
PubMed (2016) Vol. 89, Iss. 4, pp. 471-486
Closed Access | Times Cited: 41

Epigenetics in formation, function, and failure of the endocrine pancreas
Maria L. Golson, Klaus H. Kaestner
Molecular Metabolism (2017) Vol. 6, Iss. 9, pp. 1066-1076
Open Access | Times Cited: 40

Targeted demethylation of the SARI promotor impairs colon tumour growth
Qin Wang, Lei Dai, Yuan Wang, et al.
Cancer Letters (2019) Vol. 448, pp. 132-143
Closed Access | Times Cited: 39

Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing
Letizia Fontana, Zoe Alahouzou, Annarita Miccio, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 577-577
Open Access | Times Cited: 12

Functional characterization of age-dependent p16 epimutation reveals biological drivers and therapeutic targets for colorectal cancer
Li Yang, Xiaohong Chen, Christy Lee, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 12

Creation of versatile cloning platforms for transgene expression and dCas9-based epigenome editing
Jonathan M. Haldeman, Amanda E. Conway, Michelle Arlotto, et al.
Nucleic Acids Research (2018) Vol. 47, Iss. 4, pp. e23-e23
Open Access | Times Cited: 34

Scroll to top